The significant drop in Eiger BioPharmaceuticals' stock price by 55.6% directly impacts investor sentiment and could lead to increased volatility and potential sell-off in the short term. The circuit breaker halt indicates a sudden and substantial move, which often results in heightened attention from both investors and traders, potentially exacerbating the stock's volatility upon resumption.